An ASNC Information Statement: Radiopharmaceutical supply disruptions and the use of 99mTc-hydroxymethylene diphosphonate as an alternative to 99mTc-pyrophosphate for the diagnosis of transthyretin cardiac amyloidosis
Resource Type
Information Statements, Practice Points
Year Published
2022
Related Resources
Cardiovascular Organizations Comment on OMB Proposed Regulation on Federal Financial Assistance
ASNC-ACC-ASE-SCAI-SCCT_Comments letter to OMB_07-13-2026
Scientific Societies Oppose Restrictions on Federal Research Grants
163 scientific societies letter opposing federal grant restrictions_06-18-2026
National Medical Organizations Applaud WISeR Amendment, Seek Reforms
Medical-Orgs-Applaud-WISeR-Amdt_Seek-Reforms_11-13-2025
